Table 3.

Distribution of deaths by country in PLATO.

Country*	Patients enrolled	Deaths; Clopidogrel/Ticagrelor; (%)†
Argentina	410	40; 21/19; (9.76)
Australia	83	3; 1/2; (3.61)
Austria	143	5; 3/2; (3.50)
Belgium	170	8; 7/1; (4.71)
Brazil	590	62; 41/21; (10.51)
Bulgaria	451	32; 18/14; (7.10)
Canada	401	12; 5/7; (2.99)
China	416	21; 12/9; (5.05)
Czech Republic	1021	41; 22/19; (4.02)
Denmark	382	15; 10/5; (3.93)
Finland	154	3; 3/0; (1.95)
France	422	22; 13/9; (5.21)
Georgia	519	19; 7/12; (3.66)
Germany	1156	57; 27/30; (4.93)
Greece	90	4; 3/1; (4.44)
Hungary	1267	56; 36/20; (4.42)
India	575	52; 31/21; (9.04)
Indonesia	62	14; 8/6; (22.58)
Israel	636	21; 12/9; (3.30)
Italy	625	11; 8/3 (1.76)
Malaysia	56	8; 6/2 (14.29)
Mexico	137	12; 6/6 (8.76)
Netherlands	913	22; 17/5 (2.41)
Norway	159	5; 1/4 (3.14)
Philippines	78	16; 10/6 (23.66)
Poland	2666	104; 51/53; (3.90)
Portugal	152	8; 3/5; (5.26)
Romania	397	22; 14/8 (5.54)
Russia	678	48; 19/29; (7.08)
South Korea	120	4; 3/1; (3.33)
Singapore	64	3; 3/0; (4.69)
Slovakia	336	20; 11/9; (5.95)
South Africa	149	17; 8/9; (11.41)
Spain	314	13; 9/4 (4.14)
Sweden	347	12; 6/6 (3.46)
Switzerland	211	8; 5/3 (3.79)
Taiwan	92	8; 2/6 (8.70)
Thailand	152	32; 19/13 (21.05)
Turkey	51	8; 6/2 (15.69)
United Kingdom	281	14; 9/5 (4.98)
Ukraine	169	13; 8/5 (7.69)
USA	1413	53; 24/29 (3.75)

^*No deaths reported among 16 patients enrolled at a single site in Hong Kong.

^†C – clopidogrel; T – ticagrelor; % - overall death rate combined for both drugs.